During the past decade, Herzzentrum Leipzig Universitätsklinik für Kardiologie conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Herzzentrum Leipzig Universitätsklinik für Kardiologie" #1 collaborator was "Janssen Biotech, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Herzzentrum Leipzig Universitätsklinik für Kardiologie" are "Degenerative Mitral Valve Disease" (1 trials), "Functional Mitral Regurgitation" (1 trials), "Mitral Insufficiency" (1 trials), "Mitral Regurgitation" (1 trials) and "Monomorphic Ventricular Tachycardia" (1 trials). Many other conditions were trialed in "Herzzentrum Leipzig Universitätsklinik für Kardiologie" in a lesser frequency.

Most popular intervention types in "Herzzentrum Leipzig Universitätsklinik für Kardiologie" are "Device" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abbott Mitraclip System" (1 trials), "Ablation in the ventricles with the Adagio Medical VT Cryoablation System" (1 trials), "Aprocitentan 12.5 mg" (1 trials), "Aprocitentan 25 mg" (1 trials) and "Edwards PASCAL System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Herzzentrum Leipzig Universitätsklinik für Kardiologie" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Herzzentrum Leipzig Universitätsklinik für Kardiologie". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Herzzentrum Leipzig Universitätsklinik für Kardiologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Herzzentrum Leipzig Universitätsklinik für Kardiologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".